Pieris Pharmaceuticals, Inc. Completes Private Placement, Raises $13.6M
Marketwired (press release) In connection with the private placement, the Company issued warrants to acquire a combined total of up to approximately 542,361 shares of its common stock at an exercise price of $2.00 per share to Northland, Katalyst, Trout and their designees. |